How to Value a Private Company for Sale: DCF, Comps, and Bridging the Gap

If you are asking how to value a private company for sale, the honest first answer is that you are not solving for a number — you are building a defensible range. There is no observable market price for a private business, so value is reconstructed from three lenses: a discounted cash flow (DCF) of what the company will earn, comparable company analysis of what similar public businesses trade for, and precedent transaction analysis of what real acquirers actually paid. Each lens distorts differently. The skill is not running the methods — software does that — it is knowing which one leads, where each one lies to you, and how to reconcile them into a number that survives a buyer's interrogation.

The stakes for getting this right have risen with the market. US private equity deal value rose roughly 8% year over year to just over $195 billion in the first half of 2025, with buyers sitting on close to $880 billion in dry powder as the bid-ask gap that froze 2022-2023 finally began to narrow. More capital chasing deals does not make your number easier to defend — it makes the diligence on it sharper. This guide walks through the three methods, how to triangulate them, why buyer and seller numbers diverge, and how structure — not just analysis — gets a deal closed at a price you can live with.

Why Your Valuation Is a Range, Not a Number

The single most common mistake owners make is treating valuation as arithmetic. You multiply EBITDA by a multiple a broker mentioned, get one figure, and anchor to it emotionally. A serious buyer does the opposite: they build a distribution. They run a DCF under three growth cases, pull a set of trading comps, screen precedent deals, and look at where the methods cluster and where they diverge. The clustering is your defensible range. The divergence tells them — and should tell you — which assumptions the whole valuation hangs on.

The Three Core Private Company Valuation Methods and When Each One Leads

Among private company valuation methods, three do almost all the work. Each answers a slightly different question, and each should lead in a different situation.

Discounted Cash Flow (DCF): intrinsic value, maximum assumption risk

DCF projects the company's unlevered free cash flow forward, then discounts it back at a rate that reflects its risk. It is the only method grounded in the business itself rather than in what other companies are worth, which makes it the right lead for a company whose future looks materially different from its past — a new product line ramping, a margin inflection, a roll-up mid-build. Its weakness is unforgiving: small changes in the discount rate or the terminal growth assumption swing the answer enormously, so a DCF is only as defensible as the assumptions feeding it. This is precisely where a buyer's team will push hardest.

Comparable companies (trading comps): the public-market floor

Trading comps value your business off the multiples — EV/EBITDA, EV/Revenue — at which similar public companies trade today. The logic is fast and market-tested, and it is the natural lead when there is a clean public peer set. The catch for private sellers: public multiples reflect minority, liquid stakes. They carry no control premium and assume you can sell a share tomorrow. For a private, illiquid, control-block sale, trading comps usually mark the lower boundary of a credible range.

Precedent transactions: what acquirers actually paid

Precedent (or transaction) comps look at multiples paid in completed M&A deals for similar businesses, typically drawn from real transactions over the prior three to five years so the macro environment is broadly comparable. Because these are acquisition prices, they embed a control premium — and that premium is large. As Wall Street Prep notes, control premiums can run 25% to 50%+ above unaffected trading prices, which is why transaction comps usually produce the highest of the three method values. Their weakness is staleness and disclosure: deal terms are often partial, and a transaction from a hotter cycle can flatter your number in a way diligence will quickly strip out.

Triangulating to a Defensible Range

No single method is right. The output is the overlap. You run all three, plot the implied values, and look for where they converge — that band is your defensible range. The debate over DCF vs comparables vs precedent transactions is not which one wins; it is what each one is telling you about a different dimension of value, and which deserves the most weight given your specific situation.

Why Buyer and Seller Numbers Diverge: The Valuation Gap

Even with identical methods, buyer and seller arrive at different numbers — and they are supposed to. You price the upside you can see from the inside: the pipeline, the planned launch, the loyal customers. The buyer prices the risk they can see from the outside: customer concentration, key-person dependence, working-capital swings, the gap between reported and normalized EBITDA. This is the valuation gap, and it is not a sign anyone is being unreasonable. It is the difference between an insider's confidence and an outsider's caution, expressed in dollars.

The gap is also where deals die. In Axial's 2025 analysis of broken letters of intent, QoE EBITDA discrepancies caused 21.3% of failed deals — situations where a quality-of-earnings review found that real, defensible EBITDA was lower than the number the price was struck on. Non-QoE diligence findings accounted for another 25.3%. In other words, roughly half of dead deals collapse not over strategy but over the integrity of the financial inputs. The lesson is blunt: the surest way to protect your valuation is to make sure your starting number is one diligence cannot puncture. That is the entire premise of getting diligence-ready before you raise or sell.

Bridging the Valuation Gap With Structure: Earn-Outs and Deferred Consideration

When the gap will not close on price alone, you close it on structure. Instead of arguing the headline number down, you change the shape of the consideration so each side gets to keep its view of value. The three workhorses are earn-out structuring, deferred consideration, and rollover equity.

• Earn-out — a portion of the price is paid later, contingent on the business hitting defined targets after close. It lets the seller capture the upside they believe in and protects the buyer from paying for performance that never arrives.
• Deferred consideration — agreed value paid on a fixed future schedule rather than tied to performance. Lower dispute risk than an earn-out, but the seller carries the buyer's credit risk.
• Rollover equity — the seller reinvests part of their proceeds into the combined entity, aligning both parties on the second exit and signaling genuine confidence in the forward story.

Earn-outs are the most common bridge — and the most dangerous if drafted loosely. Usage has come down from its peak: SRS Acquiom's deal-terms data shows earn-outs in private targets fell from a high of roughly 30-37% of deals in 2023 to about 22% in 2024, as sellers regained leverage in a more competitive buy-side market and pushed for more value upfront. The contingent dollars do not always materialize either — across deals with earn-outs, payouts have historically averaged only around 21 cents on the dollar. An earn-out is a real bridge, but you should price it as the discounted, at-risk consideration it is.

Locked-Box vs Completion Accounts: Protecting Value at Close

Bridging the gap on headline price is one thing; protecting the value between signing and closing is another. That is the job of the price-adjustment mechanism, and the choice is locked-box vs completion accounts.

Locked box: price fixed, certainty high

A locked-box deal fixes the price at a historical "locked-box date" — usually a recent audited balance sheet — with protections against leakage (value leaving the business to the seller, like dividends, before close). The price does not reopen. It is the more common mechanism in European M&A precisely because it gives both sides certainty at signing and far less post-closing friction. For a seller, that certainty is a feature: you know your number.

Completion accounts: price trued-up, certainty deferred

Completion accounts — still the prevalent mechanism in US deals — set a provisional price that is adjusted after close once final accounts are drawn up, typically for working capital, net debt, and cash. The truer economic picture is the upside; the downside is that the final number is unknown until weeks after the deal closes, and the adjustment itself is a frequent source of dispute. As a seller, you trade certainty for accuracy — and you take on the risk of a post-close clawback.

How to Value a Private Company for Sale When Comparables Are Scarce

Triangulation assumes you have a triangle. For crypto-native and other novel businesses, two of the three legs wobble: clean public comps barely exist, and precedent transactions are sparse, often privately disclosed, and struck across wildly different market regimes. The honest answer to how to value a private company for sale in these cases is that the burden shifts onto DCF and onto first-principles judgment — and onto disclosure. You lean harder on scenario-driven cash-flow modeling, you treat the few available comps as directional rather than definitive, and you over-document every assumption, because a buyer's first instinct will be to discount what they cannot benchmark. For digital-asset businesses, that also means valuation work has to sit on books that already reconcile under the current accounting regime; scarce comps and shaky records together are how a deal stalls.

A Valuation That Survives Interrogation: Senior Judgment Plus AI Leverage

Everything above points to one conclusion: a valuation is only as good as its ability to survive interrogation. A buyer's diligence team is paid to find the soft assumption, the cherry-picked comp, the EBITDA add-back that does not hold. A number that cracks under that pressure does not just get negotiated down — it can break the deal entirely, as the broken-LOI data shows.

This is the core of how OpsFi approaches valuation and deal structuring. The judgment calls — which method leads, how to weight a thin comp set, whether a forecast assumption is defensible or hopeful, how to draft an earn-out metric that will not end up in Chancery — are made by senior practitioners who have sat on both sides of the table and run diligence on companies as often as they have prepared them for it. That experience is not delegated to juniors and it is not handed to a model.

Where the AI-native, human-in-the-loop model earns its keep is in breadth and speed. A model built to be pushed on needs to be pushed on first — across far more scenarios, sensitivity grids, and comparable screens than a human can run by hand before a deadline. AI lets the team test the valuation against dozens of cases, surface the variables that actually move the answer, and pressure-test every assumption before the buyer does, so the senior judgment sits on top of a wider, more thorough analytical base. The result is the only kind of number worth presenting: one that has already been interrogated, and held.

Preparing the underlying numbers so they hold up is its own discipline — the work of getting your business sale-ready before you go to market. The valuation is the headline; readiness is what makes the headline credible.